Literature DB >> 3967810

Abnormal gallbladder emptying in a subgroup of patients with gallstones.

I S Pomeranz, E A Shaffer.   

Abstract

Gallbladder stasis has been implicated in gallstone formation. Gallbladder filling and emptying were quantitated by computer-assisted cholescintigraphy in 41 normal subjects versus 26 patients with gallstones. Gallbladder contraction was induced by low-dose (1.2 U/kg . h) cholecystokinin infusion. Gallstone patients exhibited normal gallbladder filling, but emptying was significantly (p less than 0.01) reduced compared with controls. On closer inspection, the patients fell into two subgroups, separated by t1/2, the time to empty 50% of gallbladder contents, 19.1 min (mean + 2 SD of control). Fifteen patients (57.7%) with a normal t1/2 (less than 19.1 min) exhibited both normal filling and normal emptying. The remaining 11 patients (43.3%) with t1/2 greater than 19.1 min had grossly abnormal gallbladder emptying, significantly (p less than 0.001) different from both the previous patient subgroup and the controls. There was no significant difference in age, sex, prevalence of obesity, presence or absence of biliary colic, and gallstone size, number, or calcification between these two subgroups. Thus, defective gallbladder emptying is evident in a subgroup of gallstone patients, and is independent of clinical features, stone size, and number. Impaired emptying should be considered when assessing pathogenesis or medical therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3967810     DOI: 10.1016/0016-5085(85)90152-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  62 in total

Review 1.  Functional disorders of the biliary tract and pancreas.

Authors:  E Corazziari; E A Shaffer; W J Hogan; S Sherman; J Toouli
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 2.  Biliary motility.

Authors:  P A Grace; G J Poston; R C Williamson
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

3.  Ultrasonographic assessment of the gallbladder in 21 children with portal vein thrombosis.

Authors:  Roberto M Yamada; Gabriel Hessel
Journal:  Pediatr Radiol       Date:  2004-10-12

4.  Effects of cholecystectomy on the kinetics of primary and secondary bile acids.

Authors:  F Berr; F Stellaard; E Pratschke; G Paumgartner
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

5.  Effect of aspirin on gallbladder motility in patients with gallstone disease. A randomized, double-blind, placebo-controlled trial of two dosage schedules.

Authors:  A Das; S S Baijal; V A Saraswat
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

6.  Altered migrating myoelectrical complex in an animal model of cholesterol gallstone disease: the effect of erythromycin.

Authors:  Q W Xu; R B Scott; D T Tan; E A Shaffer
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

7.  Cholelithiatic human gallbladders in vitro fail to respond to cholecystokinin but are responsive to carbachol, histamine, or electrical stimulation.

Authors:  Shripad B Deshpande; Narendra K Gupta; Vijay K Shukla
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

8.  Alterations in gallbladder emptying and bile retention in the absence of changes in bile lithogenicity in postmenopausal women on hormone replacement therapy.

Authors:  Radha K Dhiman; Pralay K Sarkar; Arpita Sharma; Kala Vasishta; Krishan K Kohli; Sanjay Gupta; Sudha Suri; Yogesh Chawla
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

9.  Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice.

Authors:  Helen H Wang; Piero Portincasa; Min Liu; Patrick Tso; Linda C Samuelson; David Q-H Wang
Journal:  Biochim Biophys Acta       Date:  2009-10-22

10.  Disorders of bile acid metabolism in cholesterol gallstone disease.

Authors:  F Berr; E Pratschke; S Fischer; G Paumgartner
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.